» Articles » PMID: 20435778

Differential Beta-lactam Resistance Response Driven by AmpD or DacB (PBP4) Inactivation in Genetically Diverse Pseudomonas Aeruginosa Strains

Overview
Date 2010 May 4
PMID 20435778
Citations 30
Authors
Affiliations
Soon will be listed here.
Citing Articles

Ceftazidime/avibactam resistance is associated with PER-3-producing ST309 lineage in Chilean clinical isolates of non-carbapenemase producing .

Soto K, Alcalde-Rico M, Ugalde J, Olivares-Pacheco J, Quiroz V, Brito B Front Cell Infect Microbiol. 2024; 14:1410834.

PMID: 38903939 PMC: 11188487. DOI: 10.3389/fcimb.2024.1410834.


In host evolution of beta lactam resistance during active treatment for bacteremia.

Spottiswoode N, Hao S, Sanchez-Guerrero E, Detweiler A, Mekonen H, Neff N Front Cell Infect Microbiol. 2023; 13:1241608.

PMID: 37712060 PMC: 10499174. DOI: 10.3389/fcimb.2023.1241608.


Nutrient Limitation Sensitizes to Vancomycin.

Chan D, Dykema K, Fatima M, Harvey H, Qaderi I, Burrows L ACS Infect Dis. 2023; 9(7):1408-1423.

PMID: 37279282 PMC: 10353551. DOI: 10.1021/acsinfecdis.3c00167.


Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex.

Ramsay K, Rehman A, Wardell S, Martin L, Bell S, Patrick W PLoS One. 2023; 18(5):e0285856.

PMID: 37192202 PMC: 10187892. DOI: 10.1371/journal.pone.0285856.


Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa.

Sadek M, Le Guern R, Kipnis E, Gosset P, Poirel L, Dessein R Eur J Clin Microbiol Infect Dis. 2022; 42(1):61-66.

PMID: 36376766 PMC: 9816264. DOI: 10.1007/s10096-022-04526-0.